AstraZeneca signs $2 billion agreement with Quell to develop cell therapies
(Reuters) – AstraZeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion..
Headlines
Headlines
(Reuters) – AstraZeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion..
Headlines
NEW DELHI/HONG KONG (Reuters) -Nomura Holdings’ India Head of Investment Banking Utpal Oza has stepped down from the firm, sourc..
Headlines
(Reuters) -French software provider Dassault Systemes on Friday forecast a doubling of its earnings per share (EPS) by 2028, and annou..
Headlines
(Reuters) – A group of Japanese investors are planning to file lawsuits against some brokerages based in the country, including ..
Headlines
NEW YORK (Reuters) – The judge overseeing FTX’s U.S. bankruptcy said Thursday that he would not defer to a Bahamian court ..
Headlines
BERLIN (Reuters) – The phasedown of fossil fuels is inevitable, the United Arab Emirates’ incoming COP28 president said on..
Headlines
DUBLIN (Reuters) – CRH shareholders on Thursday approved a plan to move the building materials company’s primary stock mar..
Headlines
(Reuters) – Meta Platforms on Thursday introduced WhatsApp Channels, a feature that the social media giant said would help make ..
Headlines
MOSCOW (Reuters) -The Kremlin, commenting on a report that the United States had known last year of a Ukrainian plan to attack the Nor..
Headlines
BERLIN (Reuters) – China’s decision to abandon its strict “zero-COVID” policy has not sparked a rebound in Ger..
Headlines